[Question] the UK — has anyone got a straight answer on 503A
Posting this because I searched for it and got nothing useful.
Setup: 10mg, week 65, injection-site soreness present but not ruining anything. I changed exactly one variable — state board — and tracked it for 9 weeks.
Result: a difference, but a small one, and well inside what I would call noise if someone else posted it. So I am putting it here rather than presenting it as a finding. If two or three other people have done the same thing we might actually learn something.
Not medical advice, obviously. This is one person with a spreadsheet.
best — the order this archive was captured in
The confident tone is doing a lot of work that the evidence is not.
Asked 16 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
Asked 16 compounders about API source.
Disagree on that part. 97.4% and 98.3% on the same vial is normal.
Yeah, 503A and 503B are different regulatory animals.
Retitled to remove editorialising. Put the evidence in the body.
Not to be pedantic but compounding and API source are being used interchangeably and they are not interchangeable in real life.
The confident tone is doing a lot of work that the evidence is not.
Did they tell you their API source or dodge the question?
API source questions are on-topic and compounders dodging them is newsworthy
telehealth prescriber models exist, pricing differs by state
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
the shortage list is temporary, it ends and compounding becomes illegal again
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
- 1The confident tone is doing a lot of work that the evidence is not.4 comments in this branch · started by u/usp_appendix
- 2Retitled to remove editorialising. Put the evidence in the body.4 comments in this branch · started by u/formulary_fighter